Vinati Organics announces ₹500 crore capex plan for specialty chemical projects
Vinati Organics Ltd · Chemicals & Petrochemicals
What the filing says
- Board approved ₹500 crore capital expenditure for Vinati Organics and wholly owned subsidiary Veeral Organics Pvt Ltd
- Capex to fund greenfield projects in specialty chemicals for resins, fragrances, personal care, water treatment, oil field applications
- Projects to be entirely funded through internal accruals and expected to be commissioned within two years
Why it's rated notable: the amount is 21% of annual revenue (20% to 50%)
Original filing
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 On Capital Expenditure Plan
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other capex / expansion filings this fortnight
- Studds Accessories Ltd starts commercial production at new Manufacturing Facility-V
- Sagar Cements Q2 FY27 un-audited results: consolidated loss after tax ₹5,154 lakhs
- Elevate Campuses Limited expands hostel services at O.P. Jindal Global University
- Waaree Energies Ltd subsidiary starts commercial production of 1.6 GW solar lines in USA
- Max Healthcare Institute Limited announces Q2 2026 results and expansion plans
- Monolithisch India Limited Q2 H1 FY27 earnings call transcript and operational update
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.